| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/27/1999 | CA2164804C Nk-1 receptor antagonists for the treatment of neuronal injury and stroke |
| 07/27/1999 | CA2155837C Benzopyrans as potassium channel openers |
| 07/27/1999 | CA2009074C Improvements in and relating to guanidine derivatives |
| 07/22/1999 | WO1999036443A1 Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same |
| 07/22/1999 | WO1999036439A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation |
| 07/22/1999 | WO1999036425A1 Platelet adp receptor inhibitors |
| 07/22/1999 | WO1999036421A1 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists |
| 07/22/1999 | WO1999036418A1 Substituted bicyclic lactones |
| 07/22/1999 | WO1999036417A1 SUBSTITUTED β,η-ANELLATED LACTONES |
| 07/22/1999 | WO1999036416A1 SUBSTITUTED α,β-ANELLATED BUTYROLACTONES |
| 07/22/1999 | WO1999036392A1 Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 07/22/1999 | WO1999036069A1 Il-8 receptor antagonists |
| 07/22/1999 | WO1999030157A3 Neuropilins in methods for diagnosis and prognosis of cancer |
| 07/22/1999 | DE19801647A1 New beta, gamma-fused lactone glutamate receptor modulators for treating cerebral ischemia, cranial or brain trauma, pain or CNS-mediated spasms |
| 07/22/1999 | DE19801646A1 New bicyclic lactone glutamate receptor modulators for treating cerebral ischemia, cranial/brain trauma, pain or CNS-mediated spasms |
| 07/22/1999 | DE19801636A1 New bi:cyclic lactone glutamate receptor modulators |
| 07/22/1999 | CA2318358A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation |
| 07/22/1999 | CA2318199A1 Platelet adp receptor inhibitors |
| 07/22/1999 | CA2318195A1 Il-8 receptor antagonists |
| 07/21/1999 | EP0930310A1 Isocoumarin derivatives and use thereof in drugs |
| 07/21/1999 | EP0930076A1 Medicinal compositions |
| 07/21/1999 | EP0929578A1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 07/21/1999 | EP0929572A1 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| 07/21/1999 | EP0929571A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 07/21/1999 | EP0929554A1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 07/21/1999 | EP0929542A1 Compounds for and a method of inhibiting matrix metalloproteinases |
| 07/21/1999 | EP0929530A1 Quinazoline derivatives and pharmaceutical compositions containing them |
| 07/21/1999 | EP0929529A2 Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed et a?/et b? endothelin receptor antagonists |
| 07/21/1999 | EP0929526A1 Qinoline derivatives inhibiting the effect of growth factors such as vegf |
| 07/21/1999 | EP0929525A2 Novel heteroaryloxyethylamines, method of preparation, application as medicine and pharmaceutical compositions containing them |
| 07/21/1999 | EP0929520A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease |
| 07/21/1999 | EP0929516A1 Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect |
| 07/21/1999 | EP0929515A1 Novel phenoxyethylamine derivatives, method of preparation, application as medicine and pharmaceutical compositions containing same |
| 07/21/1999 | EP0929306A1 Method of inhibiting smooth muscle cell proliferation |
| 07/21/1999 | EP0929218A2 P2y receptor antagonists |
| 07/21/1999 | EP0929216A1 Method of treating post menopausal diseases, including osteoporosis |
| 07/21/1999 | EP0750621B1 Heterocyclic compounds, their preparation and use |
| 07/21/1999 | EP0745092B1 Peptide inhibitors of urokinase receptor activity |
| 07/21/1999 | CN1223643A Prenyl transferase inhibitors |
| 07/21/1999 | CN1223642A Inhibitors of prenyl transferases |
| 07/21/1999 | CN1223641A Aryl pyrimidine derivatives |
| 07/21/1999 | CN1044245C Tricyclic dicarbonyl derivatives, medicinal compositions and use thereof |
| 07/21/1999 | CN1044243C Biphenyl-substituted quinoline derivatives, their medicinal composition and use thereof |
| 07/21/1999 | CN1044235C Sulfonamide endothelin antagonists |
| 07/20/1999 | US5925772 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 07/20/1999 | US5925665 Imidazoline compounds |
| 07/20/1999 | US5925650 Annelated dihydropyridines and the use thereof for preparing pharmaceutical preparations |
| 07/20/1999 | US5925646 Heterocyclic aryl-, alkyl- and cycloalkylacetamides |
| 07/20/1999 | US5925645 Arteriosclerosis |
| 07/20/1999 | US5925624 Antiinflammatory agents treating patients with inflammatory conditions susceptible to leukocyte-induced tissue damage |
| 07/20/1999 | US5925557 This invention relates generally to the field of protein kinases, oncogenes and oncoproteins and, specifically, to a protein kinase which phosphorylates and potentiates the activity of c-fos. |
| 07/20/1999 | US5925547 Nucleic acid encoding novel protein domain which binds tyrosine phosphorylated proteins |
| 07/20/1999 | US5925539 Human pelota homolog |
| 07/20/1999 | US5925521 Human serine carboxypeptidase |
| 07/20/1999 | US5925355 Preparations of Crataegus species, pharmaceutical compositions and their use for preventing sudden death due to cardiac arrest and reperfusion-caused cardiovascular lesions |
| 07/20/1999 | US5925353 Targeted radioimmunotherapy |
| 07/20/1999 | CA2146367C Calcium channel blocking polypeptides from heteropoda venatoria |
| 07/20/1999 | CA2024419C Novel bivalent metal salts of n,n-di(carboxymethyl)-2-amino-3-cyano-4-carboxymethyl-5-carboxythiophene acid, process for their preparation and pharmaceutical compositions containing them |
| 07/20/1999 | CA1340667C Peptides having bradykinin antagonist action |
| 07/15/1999 | WO1999035279A1 G protein-related kinase mutants in essential hypertension |
| 07/15/1999 | WO1999035266A2 Human urotensin ii |
| 07/15/1999 | WO1999035253A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035168A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035166A1 Compounds and methods for modulating occludin related tissue permeability |
| 07/15/1999 | WO1999035146A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 07/15/1999 | WO1999035145A1 Deprotection and recrystallization processes |
| 07/15/1999 | WO1999035143A1 Method for producing doxazodin mesylate in a crystal modification designated as form a and intermediate product for producing the same |
| 07/15/1999 | WO1999035135A1 Hypolipidemic benzothiazepine compounds |
| 07/15/1999 | WO1999035131A1 Aryl fused azapolycyclic compounds |
| 07/15/1999 | WO1999035124A1 Matrix metalloprotease inhibitors |
| 07/15/1999 | WO1999034834A1 Use of pigmented retinal epithelial cells for creation of an immune privilege site |
| 07/15/1999 | WO1999034827A1 Activated t-cells and their uses |
| 07/15/1999 | WO1999034784A2 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis |
| 07/15/1999 | WO1999034763A2 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis |
| 07/15/1999 | DE19800214A1 Verfahren zur Herstellung von Doxazosin-Mcsylat in einer als Form A bezeichneten Kristallmodifikation und ein Zwischenprodukt dafür Process for the preparation of doxazosin Mcsylat in a crystal form known as Form A and an intermediate therefor |
| 07/15/1999 | CA2351624A1 Compounds and methods for modulating tissue permeability |
| 07/15/1999 | CA2317718A1 Deprotection and recrystallization processes |
| 07/15/1999 | CA2317651A1 Hypolipidemic benzothiazepine compounds |
| 07/15/1999 | CA2317523A1 Method for producing doxazodin mesylate in a crystal modification designated as form a and intermediate product for producing the same |
| 07/15/1999 | CA2317382A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2316973A1 Secreted proteins and polynucleotides encoding them |
| 07/14/1999 | EP0928337A1 A human protein tyrosine kinase |
| 07/14/1999 | EP0928291A1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| 07/14/1999 | EP0928195A1 Compositions for use in embolizing blood vessels |
| 07/14/1999 | EP0928194A1 Compositions and methods for administering integrin receptor antagonists |
| 07/14/1999 | EP0928191A1 Pharmaceutical compositions comprising s-alkylisothiouronium derivatives |
| 07/14/1999 | EP0759079B1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1-BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel-III) |
| 07/14/1999 | EP0754234B1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1 BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICE rel-II) |
| 07/14/1999 | EP0658161B1 Substituted thiazolidinedione derivatives |
| 07/14/1999 | EP0581856B1 Method of preventing nmda receptor complex-mediated neuronal damage |
| 07/14/1999 | CN1222850A Therapeutic treatment for VEGF related occular diseases |
| 07/14/1999 | CN1222525A Cholesterol acetate extracted from sponge and its preparation |
| 07/14/1999 | CN1222521A 1,3,8-triaza-spiro [4,5] decan-4-on derivatives |
| 07/14/1999 | CN1222377A Hypertension ointment for external use |
| 07/14/1999 | CN1222374A Active Gastrodia elata and its preparation |
| 07/14/1999 | CN1222363A Preparation of Chinese medicine for curing cardiac and cerebral diseases atomized by oxygen and its preparation process |
| 07/14/1999 | CN1044116C Novel benzenesulfonylimine derivatives as inhibitors of IL-1 action and use thereof |
| 07/13/1999 | US5922887 Novel delta opiod modulators for the treatment or prophylaxis of pain, organ transplant rejection, diarrhea, epileptic seizures, neurological diseases, and other disorders |
| 07/13/1999 | US5922853 Human pelota homolog |
| 07/13/1999 | US5922772 Therapeutic substituted guanidines |